Biotronik today announced European market release of the Passeo-35 Xeo percutaneous transluminal angioplasty (PTA) balloon catheter. A company press release states that, compared to other available PTA balloons, the device offers physicians improved crossability, excellent trackability, and pushability in a wide range of sizes.
“The new Passeo-35 Xeo balloon handled impressively well, crossing easily even in an occlusive lesion,” comments Gerd Grözinger (University Hospital Tübingen, Tübingen, Germany), after performing the first-in-human procedure with the balloon. “The deflation time was also very fast compared to other balloons, which can save valuable procedure time.”
To aid in challenging lesion crossing, the Passeo-35 Xeo catheter offers a low entry profile, smooth tip taper, and up to 19.5% more pushability compared to competitors, facilitating improved catheter navigation in the peripheral vasculature. Catering to a full range of lesion sizes, the device is available in balloon diameters from 3–12mm and lengths of up to 250mm, with usable catheter lengths of 90, 130 and 170cm. Additionally, the Passeo-35 Xeo catheter is fully 5F compatible for balloon sizes up to 7mm in diameter and 250mm in length.
The Passeo-35 Xeo balloon is indicated to dilate stenosis in the iliac, femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. It is also recommended for post-dilatation of balloon-expandable and self-expanding stents in the peripheral vasculature. Passeo-35 Xeo is the platform for Biotronik’s recently released Dynetic-35 balloon-expandable cobalt chromium stent system.
